Krysan Kostyantyn, Reckamp Karen L, Sharma Sherven, Dubinett Steven M, The potential and rationale for COX-2 inhibitors in lung cancer, Anti-cancer agents in medicinal chemistry, 2006, 6 (3), 209-20.